JP2832979B2
(ja)
*
|
1988-02-15 |
1998-12-09 |
武田薬品工業株式会社 |
不飽和カルボン酸アミド誘導体
|
US5153206A
(en)
*
|
1988-12-02 |
1992-10-06 |
Pfizer Inc. |
Arylpiperidine derivatives
|
JP2777159B2
(ja)
|
1988-12-22 |
1998-07-16 |
エーザイ株式会社 |
環状アミン誘導体を含有する医薬
|
JP2969359B2
(ja)
*
|
1989-01-13 |
1999-11-02 |
武田薬品工業株式会社 |
環状アミン化合物
|
US5225402A
(en)
*
|
1989-02-10 |
1993-07-06 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
JP2931986B2
(ja)
*
|
1989-02-17 |
1999-08-09 |
武田薬品工業株式会社 |
アラルキルアミン誘導体
|
US5250528A
(en)
*
|
1989-08-02 |
1993-10-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminopiperazine derivatives
|
US5109002A
(en)
*
|
1989-09-08 |
1992-04-28 |
Du Pont Merck Pharmaceutical Company |
Antipsychotic 1-cycloalkylpiperidines
|
CA2069318A1
(en)
*
|
1989-10-27 |
1991-04-28 |
Engelbert Ciganek |
(n-phthalimidoalkyl) piperidines
|
US5356906A
(en)
*
|
1989-10-27 |
1994-10-18 |
The Du Pont Merck Pharmaceutical Company |
(N-phthalimidoalkyl) piperidines useful as treatments for psychosis
|
HUT55358A
(en)
*
|
1989-10-30 |
1991-05-28 |
Syntex Inc |
Process for producing benzylpyrrolidine derivatives with dopamin antagonist effect and pharmaceutical compositions comprising such compounds
|
US5206240A
(en)
*
|
1989-12-08 |
1993-04-27 |
Merck & Co., Inc. |
Nitrogen-containing spirocycles
|
US5032598A
(en)
*
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
|
US5032604A
(en)
*
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
US5112824A
(en)
*
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
US5215989A
(en)
*
|
1989-12-08 |
1993-06-01 |
Merck & Co., Inc. |
Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
|
JPH05503517A
(ja)
*
|
1989-12-18 |
1993-06-10 |
バージニア・コモンウェルス・ユニバーシティ |
シグマレセプターリガンド及びその用途
|
US5428043A
(en)
*
|
1990-02-08 |
1995-06-27 |
Pfizer Inc. |
Tricyclic-cyclic amines as novel cholinesterase inhibitors
|
US5272157A
(en)
*
|
1990-03-07 |
1993-12-21 |
Synthelabo |
Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application
|
FR2659323B1
(fr)
*
|
1990-03-07 |
1992-06-12 |
Synthelabo |
Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
|
US5116846A
(en)
*
|
1990-03-28 |
1992-05-26 |
Du Pont Merck Pharmaceutical Company |
N-aralkyl piperidine derivatives as psychotropic drugs
|
US5173209A
(en)
*
|
1990-05-10 |
1992-12-22 |
Cyprus Foote Mineral Company |
Stable lithium cycloalkylimides
|
DK0531410T3
(da)
*
|
1990-06-01 |
1995-01-30 |
Merrell Dow Pharma |
(+)-alfa-(2,3-Demethoxyphenyl)-1-(2-(4-fluorphenyl)ethyl)-4-piperidinmethanol
|
US6004980A
(en)
*
|
1990-06-01 |
1999-12-21 |
Merrell Pharmaceuticals, Inc. |
(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
|
JP2807577B2
(ja)
*
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
環状アミド誘導体
|
DE69123090D1
(de)
*
|
1990-07-06 |
1996-12-19 |
Yoshitomi Pharmaceutical |
Kondensierte Thiophenverbindungen und deren Verwendung
|
FR2664592B1
(fr)
*
|
1990-07-10 |
1994-09-02 |
Adir |
Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
TW199153B
(sv)
*
|
1990-08-07 |
1993-02-01 |
Dtsuka Seiyaku Kk |
|
US5190951A
(en)
*
|
1990-10-19 |
1993-03-02 |
Ss Pharmaceutical Co., Ltd. |
Quinoline derivatives
|
US5240934A
(en)
*
|
1990-10-19 |
1993-08-31 |
Ss Pharmaceutical Co., Ltd. |
Quinoline derivatives
|
TW197435B
(sv)
*
|
1990-11-22 |
1993-01-01 |
Takeda Pharm Industry Co Ltd |
|
DE4104870A1
(de)
*
|
1991-02-17 |
1992-08-27 |
Bayer Ag |
Verwendung von 3,(4)-substituierten pyrrolidinen als katalysatoren fuer das polyisocyanatpolyadditionsverfahren, verfahren zu ihrer herstellung sowie verfahren zur herstellung von polyurethan(harnstoff)en
|
US5162341A
(en)
*
|
1991-02-22 |
1992-11-10 |
Du Pont Merck Pharmaceutical Company |
Use of sigma receptor antagonists for treatment of amphetamine abuse
|
US5750542A
(en)
*
|
1993-09-28 |
1998-05-12 |
Pfizer |
Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
|
DE69232907T2
(de)
*
|
1991-03-28 |
2003-05-15 |
Eisai Co Ltd |
Neue heterocyclische/cyclische amine
|
FR2676225B1
(fr)
*
|
1991-05-03 |
1993-08-27 |
Sanofi Elf |
Nouveaux intermediaires pour la synthese de composes dialkylenepiperidino.
|
FR2676226B1
(fr)
*
|
1991-05-03 |
1993-08-27 |
Sanofi Elf |
Nouveaux intermediaires pour la synthese de composes dialkylenepiperidino.
|
CA2067475C
(en)
*
|
1991-05-08 |
2000-10-10 |
Yasuo Oshiro |
Carbostyril derivatives and their use
|
US5556857A
(en)
*
|
1991-05-08 |
1996-09-17 |
Otsuka Pharmaceutical Co., Ltd. |
Disturbance-of-consciousness improving agent
|
FR2677019B1
(fr)
*
|
1991-05-27 |
1994-11-25 |
Pf Medicament |
Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
|
US5106856A
(en)
*
|
1991-06-07 |
1992-04-21 |
Hoechst-Roussel Pharmaceuticals Inc. |
[(Arylalkylpiperidin-4-yl)methyl]-2a,3,4,5-tetrahydro-1(2H)-acenaphthylen-1-ones and related compounds
|
EP0535496A1
(en)
|
1991-09-25 |
1993-04-07 |
Hoechst-Roussel Pharmaceuticals Incorporated |
(1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments
|
TW263504B
(sv)
*
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
SE9103752D0
(sv)
*
|
1991-12-18 |
1991-12-18 |
Astra Ab |
New compounds
|
US5462934A
(en)
*
|
1992-03-09 |
1995-10-31 |
Takeda Chemical Industries |
Condensed heterocyclic ketone derivatives and their use
|
ATE194982T1
(de)
*
|
1992-04-24 |
2000-08-15 |
Takeda Chemical Industries Ltd |
Benzoxazepin-derivate als cholinesterase- inhibitoren
|
WO1994007890A1
(en)
*
|
1992-10-05 |
1994-04-14 |
Ube Industries, Ltd. |
Pyrimidine compound
|
US5914328A
(en)
*
|
1992-10-09 |
1999-06-22 |
Abbott Laboratories |
Heterocyclic ether compounds useful in controlling neurotransmitter release
|
US5948793A
(en)
*
|
1992-10-09 |
1999-09-07 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
|
TW248556B
(sv)
*
|
1993-01-18 |
1995-06-01 |
Takeda Pharm Industry Co |
|
PT650476E
(pt)
*
|
1993-04-07 |
2002-11-29 |
Otsuka Pharma Co Ltd |
Agente vasodilatador periferico que contem derivados n-acilados de 4-amino-piperidina como ingredientes activos
|
US5459151A
(en)
*
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
CA2166100A1
(en)
*
|
1993-06-23 |
1995-01-05 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
DK0637586T3
(da)
*
|
1993-08-05 |
1999-12-06 |
Hoechst Marion Roussel Inc |
2-(Piperidin-4-yl, pyridin-4-yl og tetrahydropyridin-4-yl)-benzofuran-7-carbamatderivater, deres fremstilling og anvendelse
|
GB9319534D0
(en)
*
|
1993-09-22 |
1993-11-10 |
Boots Co Plc |
Therapeutic agents
|
EP0724552B1
(en)
*
|
1993-11-30 |
1997-10-29 |
Pfizer Inc. |
Process for preparing a chiral tetralone
|
DE4439822A1
(de)
|
1994-11-08 |
1996-08-29 |
Bayer Ag |
Verfahren zur Herstellung von Benzyl-piperidylmethyl-indanonen
|
US5658909A
(en)
|
1994-11-17 |
1997-08-19 |
Molecular Geriatrics Corporation |
Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
|
US6214994B1
(en)
|
1997-04-21 |
2001-04-10 |
Molecular Geriatrics Corporation |
Certain substituted 1-aryl-3-piperazin-1′-yl propanones
|
US5859295A
(en)
*
|
1994-12-05 |
1999-01-12 |
University Of Kentucky Research Foundation |
Canavanine analogs and their use as chemotherapeutic agents
|
WO1996022280A1
(de)
*
|
1995-01-18 |
1996-07-25 |
Bayer Aktiengesellschaft |
N-substituierte-1-acylaminoalkyl piperidine zur behandlung von cerebralen störungen und depressionen
|
US5889006A
(en)
*
|
1995-02-23 |
1999-03-30 |
Schering Corporation |
Muscarinic antagonists
|
IL117149A0
(en)
*
|
1995-02-23 |
1996-06-18 |
Schering Corp |
Muscarinic antagonists
|
US5703239A
(en)
*
|
1995-06-02 |
1997-12-30 |
Bristol-Myers Squibb Company |
Indanylpiperidines as melatonergic agents
|
US20100210590A1
(en)
*
|
1995-09-27 |
2010-08-19 |
Northwestern University |
Compositions and treatments for seizure-related disorders
|
IL136421A0
(en)
*
|
1995-12-15 |
2001-06-14 |
Pfizer |
Intermediates for preparing 1-benzyl -4-((5,6- dimethoxy -1-indanon)-2-yl) methylpiperidine
|
US6025355A
(en)
|
1997-05-19 |
2000-02-15 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
US5629325A
(en)
*
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US6437138B1
(en)
|
1996-06-06 |
2002-08-20 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
AU1153097A
(en)
*
|
1996-06-07 |
1998-01-05 |
Eisai Co. Ltd. |
Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production
|
WO1997046527A1
(en)
*
|
1996-06-07 |
1997-12-11 |
Eisai Co., Ltd. |
Polymorphs of donepezil hydrochloride and process for production
|
TW513409B
(en)
*
|
1996-06-07 |
2002-12-11 |
Eisai Co Ltd |
Polymorphs of donepezil hydrochloride
|
US5935958A
(en)
*
|
1996-07-01 |
1999-08-10 |
Schering Corporation |
Muscarinic antagonists
|
FR2750991A1
(fr)
*
|
1996-07-12 |
1998-01-16 |
Pf Medicament |
Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
|
US6242198B1
(en)
|
1996-07-25 |
2001-06-05 |
Cambridge Neuroscience, Inc. |
Methods of treatment of eye trauma and disorders
|
US6756389B2
(en)
|
1996-08-09 |
2004-06-29 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
US5977138A
(en)
*
|
1996-08-15 |
1999-11-02 |
Schering Corporation |
Ether muscarinic antagonists
|
EP0934932A4
(en)
*
|
1996-08-22 |
2002-06-26 |
Meiji Seika Kaisha |
CHINOLINE DERIVATIVES AND PSYCHOTROPES MEDIUM
|
FR2752732B1
(fr)
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
US6133253A
(en)
*
|
1996-12-10 |
2000-10-17 |
Abbott Laboratories |
3-Pyridyl enantiomers and their use as analgesics
|
US5962535A
(en)
*
|
1997-01-17 |
1999-10-05 |
Takeda Chemical Industries, Ltd. |
Composition for alzheimer's disease
|
DE19707655A1
(de)
*
|
1997-02-26 |
1998-08-27 |
Hoechst Ag |
Kombinationspräparat zur Anwendung bei Demenz
|
AU743609B2
(en)
*
|
1997-03-03 |
2002-01-31 |
Eisai Co. Ltd. |
Use of cholinesterase inhibitors to treat disorders of attention
|
AU7799998A
(en)
*
|
1997-06-11 |
1998-12-30 |
Alcon Laboratories, Inc. |
Method to reverse mydriasis
|
US6028083A
(en)
*
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
US5945421A
(en)
*
|
1997-08-11 |
1999-08-31 |
Warner-Lambert Company |
Dopamine D4 receptor antagonists
|
US6339087B1
(en)
|
1997-08-18 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Cyclic amine derivatives-CCR-3 receptor antagonists
|
IL125658A0
(en)
|
1997-08-18 |
1999-04-11 |
Hoffmann La Roche |
Ccr-3 receptor antagonists
|
CA2304505A1
(en)
*
|
1997-09-24 |
1999-04-01 |
Nova Molecular, Inc. |
Methods for increasing apoe levels for the treatment of neurodegenerative disease
|
ES2218869T3
(es)
*
|
1997-12-05 |
2004-11-16 |
Eisai Co., Ltd. |
Cristales polimorficos de donepezil y un proceso para produccion de dichos cristales.
|
WO1999036405A1
(en)
|
1998-01-16 |
1999-07-22 |
Eisai Co., Ltd. |
Process for production of donepezil derivative
|
US6713627B2
(en)
|
1998-03-13 |
2004-03-30 |
Aventis Pharmaceuticals Inc. |
Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
|
US6066636A
(en)
*
|
1998-06-30 |
2000-05-23 |
Schering Corporation |
Muscarinic antagonists
|
US6262081B1
(en)
|
1998-07-10 |
2001-07-17 |
Dupont Pharmaceuticals Company |
Composition for and method of treating neurological disorders
|
US6218383B1
(en)
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
IL125809A
(en)
*
|
1998-08-17 |
2005-08-31 |
Finetech Lab Ltd |
Process and intermediates for production of donepezil and related compounds
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
WO2000018391A1
(fr)
*
|
1998-09-30 |
2000-04-06 |
Takeda Chemical Industries, Ltd. |
Medicaments qui ameliorent le pouvoir de vidange de la vessie
|
US20020177593A1
(en)
|
1998-09-30 |
2002-11-28 |
Yuji Ishihara |
Agents and crystals for improving excretory potency of urinary bladder
|
ID29067A
(id)
*
|
1998-11-20 |
2001-07-26 |
Hoffmann La Roche |
Turunan pirolidina-antagonis reseptor ccr-3
|
BR9915735A
(pt)
|
1998-11-20 |
2001-09-04 |
Hoffmann La Roche |
Antagonistas receptores de ccr-3 de piperidina
|
AU2160900A
(en)
*
|
1998-12-11 |
2000-06-26 |
American Biogenetic Sciences, Inc. |
Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
|
US6277866B1
(en)
*
|
1999-03-03 |
2001-08-21 |
Eisai Co., Ltd. |
1-benzyl-4[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl]methylpiperidine
|
EP1157989B1
(en)
*
|
1999-03-03 |
2004-09-22 |
Eisai Co., Ltd. |
Fluorides of 4-substituted piperidine derivatives
|
US6833370B1
(en)
|
1999-05-21 |
2004-12-21 |
Abbott Laboratories |
Heterocycle substituted aminoazacycles useful as central nervous system agents
|
GB9914486D0
(en)
|
1999-06-21 |
1999-08-18 |
Smithkline Beecham Plc |
Medicaments
|
GB9917406D0
(en)
|
1999-07-23 |
1999-09-22 |
Smithkline Beecham Plc |
Compounds
|
CA2382117C
(en)
|
1999-09-01 |
2009-11-10 |
Eisai Co., Ltd. |
4-substituted piperidine compound
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
EP1764101A1
(en)
*
|
2000-03-03 |
2007-03-21 |
Eisai R&D Management Co., Ltd. |
Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
|
US20060183776A9
(en)
*
|
2000-03-03 |
2006-08-17 |
Eisai Co., Ltd. |
Liquid dosage formulations of donepezil
|
US20030153598A1
(en)
*
|
2000-07-25 |
2003-08-14 |
Raymond Pratt |
Methods for treating Parkinson's disease with cholinesterase inhibitors
|
DE60124730T2
(de)
|
2000-03-03 |
2007-10-04 |
Eisai R&D Management Co., Ltd. |
Neue methoden unter verwendung von cholinesteraseinhibitoren
|
JP2003530437A
(ja)
*
|
2000-04-13 |
2003-10-14 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
Aβ42低下物質
|
EP1285656A4
(en)
|
2000-04-13 |
2006-07-12 |
Eisai Co Ltd |
ACETYLCHOLINESTERASE HEMMER CONTAINING 1-BENZYLPYRIDINIUM SALT
|
WO2001098271A1
(fr)
*
|
2000-06-21 |
2001-12-27 |
Eisai Co., Ltd. |
Compose piperidine 4-substitue
|
AU2001267899A1
(en)
*
|
2000-07-03 |
2002-01-14 |
Eisai Co. Ltd. |
Pharmaceutical compositions for controlling intraocular pressure
|
CN1317276C
(zh)
*
|
2000-09-29 |
2007-05-23 |
中国科学院上海药物研究所 |
一类吲哚基哌啶类化合物及其制备方法和用途
|
JPWO2002045715A1
(ja)
*
|
2000-12-07 |
2004-04-08 |
藤沢薬品工業株式会社 |
抗痴呆効果増強剤
|
AU2002338334B8
(en)
*
|
2001-04-03 |
2008-09-18 |
Merck & Co., Inc. |
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists
|
US20030013699A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Davis Harry R. |
Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject
|
WO2003020289A1
(en)
*
|
2001-08-30 |
2003-03-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
|
WO2003024450A1
(en)
*
|
2001-09-20 |
2003-03-27 |
Eisai Co., Ltd. |
Methods for treating prion diseases
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
US20050226934A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
|
US20050249786A1
(en)
*
|
2001-09-28 |
2005-11-10 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
US20050191359A1
(en)
*
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
AU2002340232A1
(en)
*
|
2001-10-17 |
2003-04-28 |
Eisai Co., Ltd. |
Methods for treating substance abuse with cholinesterase inhibitors
|
GB0126378D0
(en)
*
|
2001-11-02 |
2002-01-02 |
Oxford Biomedica Ltd |
Antigen
|
EP1468684A4
(en)
*
|
2002-01-22 |
2008-02-27 |
Eisai R&D Man Co Ltd |
SIGMA RECEPTOR BINDING MOLECULE WITH INDANO DERIVATIVE
|
KR20040075371A
(ko)
*
|
2002-02-07 |
2004-08-27 |
에-자이가부시기가이샤 |
발모 촉진제, 경피 적용 제제 및 발모 촉진 방법
|
US20040072806A1
(en)
*
|
2002-03-15 |
2004-04-15 |
Zhi-Xing Yao |
Neuroprotective spirostenol pharmaceutical compositions
|
ATE382036T1
(de)
*
|
2002-03-29 |
2008-01-15 |
Eisai R&D Man Co Ltd |
(1-indanon)-(1,2,3,6-tetrahydropyridin)derivat
|
US20040033986A1
(en)
|
2002-05-17 |
2004-02-19 |
Protopopova Marina Nikolaevna |
Anti tubercular drug: compositions and methods
|
US7652039B2
(en)
|
2002-05-17 |
2010-01-26 |
Sequella, Inc. |
Methods of use and compositions for the diagnosis and treatment of infectious disease
|
IL165589A
(en)
|
2002-06-14 |
2012-04-30 |
Toyama Chemical Co Ltd |
Pharmaceutical preparation to improve brain function and use
|
IL150509A
(en)
*
|
2002-07-01 |
2007-07-04 |
Joseph Kaspi |
Pharmaceutical preparations containing donafazil hydrochloride
|
CA2490470A1
(en)
*
|
2002-07-02 |
2004-01-15 |
Schering Corporation |
Pyrazole urea neuropeptide y y5 receptor antagonists
|
US7148354B2
(en)
*
|
2002-07-24 |
2006-12-12 |
Dr. Reddy's Laboratories Limited |
Process for preparation of donepezil
|
IL150982A
(en)
|
2002-07-30 |
2007-02-11 |
Ori Lerman |
Process for making Donafzil
|
GB0218326D0
(en)
*
|
2002-08-07 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
WO2004037234A2
(en)
*
|
2002-10-24 |
2004-05-06 |
Merz Pharma Gmbh & Co. Kgaa |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
US20060014801A1
(en)
*
|
2002-11-22 |
2006-01-19 |
The Johns Hopkins University |
Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs
|
JP2004189706A
(ja)
*
|
2002-12-13 |
2004-07-08 |
Eisai Co Ltd |
高度アルツハイマー型痴呆治療剤
|
WO2004071431A2
(en)
*
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
US20080057491A1
(en)
*
|
2003-02-07 |
2008-03-06 |
Mckee Patrick A |
Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
|
US7439365B2
(en)
*
|
2003-11-17 |
2008-10-21 |
Usv, Ltd. |
Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
|
US7186842B2
(en)
*
|
2003-02-12 |
2007-03-06 |
Usv, Ltd. |
Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
|
US6953856B2
(en)
*
|
2003-02-12 |
2005-10-11 |
Usv, Limited |
Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
|
US6649765B1
(en)
|
2003-02-12 |
2003-11-18 |
Usv Limited, Bsd Marg. |
Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
|
US20050288330A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Avinash Naidu |
Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride)
|
CN100422148C
(zh)
*
|
2003-02-27 |
2008-10-01 |
天津药物研究院 |
工业化生产盐酸多奈哌齐的工艺方法
|
AU2004216360B2
(en)
*
|
2003-02-27 |
2009-09-17 |
Eisai R & D Management Co., Ltd. |
Pharmaceutical composition for treatment of drug dependence
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
US20060009433A1
(en)
*
|
2003-03-14 |
2006-01-12 |
Zhi-Xing Yao |
Neuroprotective spirostenol pharmaceutical compositions
|
US20070129549A1
(en)
*
|
2003-03-21 |
2007-06-07 |
Yatendra Kumar |
Stable lamotrigine pharmaceutical compositions and processes for their preparation
|
US7772399B2
(en)
*
|
2003-04-02 |
2010-08-10 |
Hetero Drugs Limited |
Process for amorphous form of donepezil hydrochloride
|
US20040229914A1
(en)
*
|
2003-04-02 |
2004-11-18 |
Dr. Reddy's Laboratories Limited |
Novel crystalline form-VI of donepezil hydrochloride and process for the preparation thereof
|
WO2004092137A1
(en)
|
2003-04-16 |
2004-10-28 |
Hetero Drugs Limited |
Novel crystalline forms of donepezil hydrochloride
|
WO2005003092A1
(en)
*
|
2003-07-01 |
2005-01-13 |
Hetero Drugs Limited |
Preparation of intermediates for acetyl cholinesterase inhibitors
|
JP2007528857A
(ja)
*
|
2003-07-11 |
2007-10-18 |
ミリアド ジェネティクス, インコーポレイテッド |
アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
|
GB0316915D0
(en)
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
RU2357734C2
(ru)
*
|
2003-07-25 |
2009-06-10 |
Ф.Хоффманн-Ля Рош Аг |
КОМБИНАЦИЯ АНТАГОНИСТА РЕЦЕПТОРА mGluR2 И ИНГИБИТОРА ФЕРМЕНТА AChE ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И/ИЛИ ХРОНИЧЕСКИХ НЕВРОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ
|
CN1280273C
(zh)
|
2003-11-05 |
2006-10-18 |
天津和美生物技术有限公司 |
合成多奈哌齐及其衍生物的方法
|
EP1689721B1
(en)
*
|
2003-11-26 |
2010-07-14 |
Pfizer Products Inc. |
Aminopyrazole derivatives as gsk-3 inhibitors
|
US20050232990A1
(en)
*
|
2003-12-31 |
2005-10-20 |
Garth Boehm |
Donepezil formulations
|
CN1300112C
(zh)
*
|
2004-01-06 |
2007-02-14 |
浙江大学 |
N-苄基-4-哌啶基甲醛的合成方法
|
US20050222123A1
(en)
|
2004-01-27 |
2005-10-06 |
North Shore-Long Island Jewish Research Institute |
Cholinesterase inhibitors for treating inflammation
|
MY142362A
(en)
*
|
2004-01-29 |
2010-11-30 |
Otsuka Pharma Co Ltd |
Pharmaceutical composition for promoting angiogenesis
|
WO2005087226A1
(en)
*
|
2004-03-05 |
2005-09-22 |
Eisai Co., Ltd. |
Cadasil treatment with cholinesterase inhibitors
|
US20070293538A1
(en)
*
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
US7795438B2
(en)
*
|
2004-04-28 |
2010-09-14 |
Eisai R&D Management Co., Ltd |
Processes for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine and hydrochloride
|
US20050252144A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Macdonald Robert A |
Veneers for walls, retaining walls and the like
|
EP1750724A4
(en)
*
|
2004-05-14 |
2008-01-23 |
Univ Johns Hopkins |
METHOD FOR ENHANCING COGNITIVE FUNCTION USING CO-ADMINISTRATION OF GABAB RECEPTOR ANTAGONIST AND ACETYLCHOLINESTERASE INHIBITOR
|
US20080045500A1
(en)
*
|
2004-07-01 |
2008-02-21 |
Eisai R&D Management Co., Ltd. |
Nerve Regeneration Stimulator
|
WO2006015338A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Dr. Reddy's Laboratories Ltd. |
Crystalline form of donepezil hydrochloride
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020853A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
HUP0401850A3
(en)
*
|
2004-09-15 |
2008-03-28 |
Egis Gyogyszergyar Nyilvanosan |
Donepezil salts for producing pharmaceutical composition
|
US7718674B2
(en)
|
2004-09-27 |
2010-05-18 |
Bridge Pharma, Inc. |
Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
|
JP2008514691A
(ja)
*
|
2004-09-29 |
2008-05-08 |
ケマジス リミティド |
薬学的に純粋な非晶質塩酸ドネペジルを製造するための精製されたマレイン酸ドネペジルの使用
|
GB2419093A
(en)
*
|
2004-10-12 |
2006-04-19 |
Ernir Snorrason |
Acetylcholinesterase inhibitors for the treatment of skin
|
EP2008660A1
(en)
*
|
2004-10-12 |
2008-12-31 |
Ernir Snorrason |
Inhibitors of acetylcholinesterase for treating skin diseases
|
ATE523199T1
(de)
*
|
2004-11-02 |
2011-09-15 |
Univ Northwestern |
Pyridazinverbindungen und verfahren
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
WO2006056845A1
(en)
*
|
2004-11-23 |
2006-06-01 |
Warner-Lambert Company Llc |
7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
|
US20060122226A1
(en)
|
2004-12-08 |
2006-06-08 |
Itai Adin |
Crystalline forms of Donepezil base
|
US8124783B2
(en)
*
|
2004-12-30 |
2012-02-28 |
Jubilant Organosys Limited |
Process for producing 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or its salt thereof via novel intermediate
|
CA2597566A1
(en)
|
2005-02-11 |
2006-08-17 |
Stephen Wills |
Treating microvasculature diseases with acetyl cholinesterase inhibitors
|
WO2006097341A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Synthon B.V. |
Process for making crystalline donepezil hydrochloride monohydrate
|
JP5180816B2
(ja)
*
|
2005-04-04 |
2013-04-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
神経変性疾患および認知症のためのジヒドロピリジン化合物
|
MX2007012374A
(es)
|
2005-04-06 |
2008-02-22 |
Adamas Pharmaceuticals Inc |
Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
|
US20080188510A1
(en)
*
|
2005-05-23 |
2008-08-07 |
Eisai R & D Management Co., Ltd. |
Novel methods using zonisamide
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
US20090171094A1
(en)
*
|
2005-07-15 |
2009-07-02 |
Kazuhide Ashizawa |
1-benzyl-4-[(5, 6-dimethoxy- 1- indanon)- 2- yl]-methyl piperidine p-toluenesulfonate or crystal thereof
|
AU2006272760A1
(en)
*
|
2005-07-22 |
2007-02-01 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
KR20080027885A
(ko)
*
|
2005-07-25 |
2008-03-28 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
1-벤질-4-[(5,6-디메톡시-1-인다논)-2-일리덴]메틸피페리딘의 제조 방법
|
US20070026075A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Jutaro Shudo |
Gelled donepezil compositions and methods for making and using the same
|
CN100436416C
(zh)
*
|
2005-07-29 |
2008-11-26 |
西南合成制药股份有限公司 |
盐酸多奈哌齐合成工艺
|
GB0515803D0
(en)
|
2005-07-30 |
2005-09-07 |
Pliva Hrvatska D O O |
Intermediate compounds
|
DE602006018503D1
(de)
*
|
2005-10-14 |
2011-01-05 |
Eisai R&D Man Co Ltd |
Verfahren zur herstellung von 1-benzyl-4-ä(5,6-dimethoxy-1indanon)-2-ylümethylpiperidin oder des hydrochlorids davon
|
WO2007043440A1
(ja)
|
2005-10-14 |
2007-04-19 |
Eisai R & D Management Co., Ltd. |
1-ベンジル-4-[(5,6-ジメトキシ-1-インダノン)-2-イル]メチルピペリジンまたはその塩酸塩の製造法
|
ES2572263T3
(es)
|
2005-10-25 |
2016-05-31 |
Shionogi & Co |
Derivados de dihidrooxazina y tetrahidropirimidina como inhibidores de BACE 1
|
JP2008280248A
(ja)
*
|
2005-11-02 |
2008-11-20 |
Eisai R & D Management Co Ltd |
アルツハイマー型痴呆症治療薬塩酸ドネペジルのプロドラッグ
|
AR057910A1
(es)
|
2005-11-18 |
2007-12-26 |
Synthon Bv |
Proceso para preparar donepezilo
|
HU227474B1
(en)
*
|
2005-12-20 |
2011-07-28 |
Richter Gedeon Nyrt |
Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
|
EP1973878B1
(en)
*
|
2006-01-04 |
2010-11-24 |
Cipla Limited |
Process and intermediate for preparation of donepezil
|
US7994328B2
(en)
|
2006-02-16 |
2011-08-09 |
Aurobindo Pharma Ltd. |
Process for the preparation of donepezil hydrochloride
|
EP1988077A4
(en)
|
2006-02-23 |
2009-09-02 |
Shionogi & Co |
NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS
|
US20100113793A1
(en)
*
|
2006-03-20 |
2010-05-06 |
Ind-Swift Laboratories Limited |
Process for the Preparation of Highly Pure Donepezil
|
WO2007127474A2
(en)
*
|
2006-04-28 |
2007-11-08 |
Northwestern University |
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
|
EP2026766A1
(en)
|
2006-05-17 |
2009-02-25 |
Synthon B.V. |
Tablet composition with a prolonged release of tamsulosin
|
US8933201B2
(en)
|
2006-06-07 |
2015-01-13 |
The Board Of Regents Of The University Of Oklahoma |
Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
|
EP2046119A2
(en)
*
|
2006-07-07 |
2009-04-15 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
CA2657681C
(en)
|
2006-07-14 |
2019-03-19 |
Ac Immune S.A. |
Humanized antibodies against beta amyloid protein
|
WO2008010235A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Torrent Pharmaceuticals Limited |
An improved process for the preparation of donepezil
|
CA2655809C
(en)
|
2006-07-21 |
2013-10-01 |
Bridge Pharma, Inc. |
Dermal anesthetic compounds
|
WO2008019431A1
(en)
*
|
2006-08-14 |
2008-02-21 |
Brc Operations Pty Limited |
Method and compositions for simultaneously regulating memory and mood
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
EP2420235A1
(en)
|
2006-10-27 |
2012-02-22 |
Medivation Neurology, Inc. |
Methods and combination therapies for treating alzheimer's disease
|
JP2010512328A
(ja)
*
|
2006-12-11 |
2010-04-22 |
レビバ ファーマシューティカルズ,インコーポレーテッド |
インダノン系コリンエステラーゼ阻害薬の組成物、合成および使用方法
|
JP2010520154A
(ja)
*
|
2007-03-05 |
2010-06-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
神経変性疾患のためのampaレセプターアンタゴニストおよびnmdaレセプターアンタゴニスト
|
KR20080092515A
(ko)
*
|
2007-04-12 |
2008-10-16 |
동화약품공업주식회사 |
도네페질 중간체의 제조방법
|
ES2476605T3
(es)
|
2007-04-24 |
2014-07-15 |
Shionogi & Co., Ltd. |
Derivados de aminohidrotiazina sustituidos con grupos cíclicos
|
JP5383483B2
(ja)
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
アルツハイマー症治療用医薬組成物
|
US20100130537A1
(en)
*
|
2007-04-26 |
2010-05-27 |
Eisai R&D Management Co., Ltd |
Cinnamide compounds for dementia
|
MX2009012117A
(es)
*
|
2007-05-09 |
2009-11-23 |
Pfizer |
Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
|
PL2157973T3
(pl)
*
|
2007-05-22 |
2015-12-31 |
Otsuka Pharma Co Ltd |
Lek zawierający pochodną karbostyrylu i donepezil do leczenia choroby Alzheimera
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
WO2008156622A1
(en)
*
|
2007-06-12 |
2008-12-24 |
Ac Immune S.A. |
Humanized antibodies to amyloid beta
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
WO2009011412A2
(en)
*
|
2007-07-13 |
2009-01-22 |
Eisai R & D Management Co., Ltd. |
Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain
|
DE102007037932A1
(de)
|
2007-08-11 |
2009-02-12 |
Alfred E. Tiefenbacher Gmbh & Co.Kg |
Donepezilhydrochlorid in amorpher Form enthaltende Tablette
|
US8304435B2
(en)
|
2007-09-12 |
2012-11-06 |
Deuteria Pharmaceuticals Inc. |
Deuterium-enriched donepezil
|
JP5426554B2
(ja)
*
|
2007-09-28 |
2014-02-26 |
天津和美生物技▲術▼有限公司 |
ドネペジル塩、その多形体、その製造方法、応用方法および組成物
|
TWI432195B
(zh)
|
2007-10-03 |
2014-04-01 |
Kowa Co |
神經細胞死亡抑制劑
|
RS53174B
(en)
*
|
2007-10-05 |
2014-06-30 |
Genentech Inc. |
USE OF ANTIAMYLOID BETA ANTIBODY IN THE EVENT OF ANY DISEASE
|
RU2571859C2
(ru)
*
|
2007-10-05 |
2015-12-20 |
Дженентек, Инк. |
Применение антитела против амилоида-бета при глазных заболеваниях
|
JP5566004B2
(ja)
|
2007-11-14 |
2014-08-06 |
株式会社Dnpファインケミカル宇都宮 |
アルコキシインダノン誘導体の製造方法
|
NZ588252A
(en)
*
|
2008-03-25 |
2012-08-31 |
Cipla Ltd |
Process for the preparation of donepezil hydrochloride
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
US8461389B2
(en)
|
2008-04-18 |
2013-06-11 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
US20090291127A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
CN102119161B
(zh)
|
2008-06-13 |
2015-07-08 |
盐野义制药株式会社 |
具有β分泌酶抑制作用的含硫杂环衍生物
|
WO2010019560A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of donepezil
|
JP2012504163A
(ja)
*
|
2008-09-30 |
2012-02-16 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
経皮持続送達ドネペジル組成物および該組成物を使用する方法
|
EP2360155A4
(en)
*
|
2008-10-22 |
2012-06-20 |
Shionogi & Co |
2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
|
US20100105916A1
(en)
*
|
2008-10-29 |
2010-04-29 |
Sterling Biotech Limited |
Processes for Preparing Donepezil
|
EP2352730A4
(en)
*
|
2008-11-07 |
2012-04-25 |
Lundbeck & Co As H |
BIOLOGICALLY ACTIVE AMIDES
|
US20100143505A1
(en)
*
|
2008-12-09 |
2010-06-10 |
Auspex Pharmaceuticals, Inc. |
Indanone inhibitors of acetylcholinesterase
|
US8247405B2
(en)
|
2008-12-10 |
2012-08-21 |
Conopco, Inc. |
Skin lightening compositions with acetylcholinesterase inhibitors
|
WO2010071216A1
(en)
|
2008-12-17 |
2010-06-24 |
Eisai R&D Management Co., Ltd. |
Polymorphic crystal of donepezil and process for producing the same
|
US8465770B2
(en)
*
|
2008-12-24 |
2013-06-18 |
Synthon Bv |
Low dose controlled release tablet
|
EP2674150A1
(de)
|
2009-01-28 |
2013-12-18 |
Labtec GmbH |
Pharmazeutische Zubereitung mit verbesserter Stabilität des Wirkstoffs
|
JP4666093B2
(ja)
*
|
2009-03-13 |
2011-04-06 |
ユニマテック株式会社 |
ポリフルオロアルキルホスホン酸エステルの製造法
|
CA2766277C
(en)
*
|
2009-07-10 |
2014-02-18 |
Unimatec Co., Ltd. |
Polyfluoroalkylphosphonic acid ester and process for producing the same
|
EP2497566B1
(en)
*
|
2009-11-04 |
2019-01-30 |
Unimatec Co., Ltd. |
Polyfluoroalkyl phosphonate salt emulsifying agent and mold release agent comprising same as active ingredient
|
WO2011061591A1
(en)
|
2009-11-18 |
2011-05-26 |
Jubilant Life Sciences Limited |
Improved process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanone)-2-yl)methyl piperidine hydrochloride form-iii
|
MX2012005637A
(es)
|
2009-11-18 |
2012-06-13 |
Suven Life Sciences Ltd |
COMPUESTOS BICICLICOS COMO LIGANDOS DEL RECEPTOR NICOTINICO DE ACETILCOLINA A4 ß2.
|
UA110467C2
(uk)
|
2009-12-11 |
2016-01-12 |
Шионогі Енд Ко., Лтд. |
Похідні оксазину
|
CN102753540B
(zh)
|
2009-12-29 |
2014-01-22 |
苏文生命科学有限公司 |
α4β2神经元烟碱型乙酰胆碱受体的配体
|
US20100178307A1
(en)
*
|
2010-01-13 |
2010-07-15 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
AU2011215870B2
(en)
|
2010-02-09 |
2016-01-28 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
WO2011127235A1
(en)
|
2010-04-07 |
2011-10-13 |
Eisai Inc. |
Combination therapy for the treatment of dementia
|
GR1007368B
(el)
|
2010-05-27 |
2011-08-02 |
Alapis Α.Β.Ε.Ε., |
Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια των συμπτωματων της ανοιας
|
WO2011151359A1
(en)
|
2010-06-02 |
2011-12-08 |
Noscira, S.A. |
Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
|
FR2962335B1
(fr)
|
2010-07-12 |
2013-01-18 |
Cll Pharma |
Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
|
WO2012016173A2
(en)
|
2010-07-30 |
2012-02-02 |
Ac Immune S.A. |
Safe and functional humanized antibodies
|
TR201007109A2
(tr)
|
2010-08-25 |
2012-03-21 |
Bi̇lgi̇ç Mahmut |
Tek birim dozaj formları.
|
TR201007110A2
(tr)
|
2010-08-25 |
2012-03-21 |
Bi̇lgi̇ç Mahmut |
Sinerjik etki gösteren kombinasyonlar
|
WO2012038966A1
(en)
|
2010-09-22 |
2012-03-29 |
Tyche Industries Ltd. |
Process for the preparation of donepezil intermediate
|
US9018219B2
(en)
|
2010-10-29 |
2015-04-28 |
Shionogi & Co., Ltd. |
Fused aminodihydropyrimidine derivative
|
WO2012057248A1
(ja)
|
2010-10-29 |
2012-05-03 |
塩野義製薬株式会社 |
ナフチリジン誘導体
|
MX346185B
(es)
|
2010-11-15 |
2017-03-10 |
Agenebio Inc |
Derivados de piridazina, composiciones y metodos para tratar deterioro cognitivo.
|
US8980924B2
(en)
|
2010-11-24 |
2015-03-17 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
TW201247635A
(en)
|
2011-04-26 |
2012-12-01 |
Shionogi & Co |
Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them
|
EP2710203B1
(de)
|
2011-05-16 |
2018-12-19 |
Weitzer Holding GmbH |
Boden- oder wandbelagsystem mit modular kombinierbaren verlegeeinheiten
|
EP2565186A1
(en)
|
2011-09-02 |
2013-03-06 |
Hybrigenics S.A. |
Selective and reversible inhibitors of ubiquitin specific protease 7
|
EP3791879A1
(en)
|
2012-04-14 |
2021-03-17 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
CN103524515B
(zh)
*
|
2012-07-03 |
2016-07-06 |
浙江海正药业股份有限公司 |
具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途
|
EP2912035A4
(en)
|
2012-10-24 |
2016-06-15 |
Shionogi & Co |
DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
|
CN103787954B
(zh)
*
|
2012-10-26 |
2016-01-20 |
中国科学院上海药物研究所 |
一类氟取代的环状胺类化合物及其制备方法、药物组合物和用途
|
WO2014078568A1
(en)
|
2012-11-14 |
2014-05-22 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
WO2014076965A1
(ja)
*
|
2012-11-16 |
2014-05-22 |
学校法人北里研究所 |
抗原虫活性を示す1-インダン誘導体
|
EP2759536A1
(en)
|
2013-01-25 |
2014-07-30 |
INSA (Institut National des Sciences Appliquees) de Rouen |
Oxidisable pyridine derivatives, their preparation and use as anti-Alzheimer agents
|
EP3827820A1
(en)
|
2013-03-15 |
2021-06-02 |
The Johns Hopkins University |
Brivaracetam for improving cognitive function
|
CN105142623A
(zh)
|
2013-03-15 |
2015-12-09 |
艾吉因生物股份有限公司 |
用于改善认知功能的方法和组合物
|
US20160067306A1
(en)
|
2013-04-19 |
2016-03-10 |
National University Corporation Hokkaido University |
Treatment agent for cognitive impairment induced by amyloid beta-protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these
|
AU2014307803A1
(en)
|
2013-08-16 |
2016-03-10 |
Universiteit Maastricht |
Treatment of cognitive impairment with PDE4 inhibitor
|
US9359315B2
(en)
|
2013-09-10 |
2016-06-07 |
Arrien Pharmaceuticals Llc |
Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
|
NZ722077A
(en)
|
2013-12-20 |
2021-12-24 |
Agenebio Inc |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
FR3018689B1
(fr)
*
|
2014-03-20 |
2017-04-28 |
Centre Hospitalier Univ De Clermont Ferrand |
Inhibiteurs de l'acetylcholinesterase d'action centrale pour la prevention et/ou le traitement des neuropathies chimio-induites et leurs symptomes, compositions, utilisations, methodes et trousse correspondantes.
|
CN105753768B
(zh)
*
|
2014-12-15 |
2020-11-27 |
北京恒瑞新霖科技有限公司 |
一种含单个氮杂环化合物的生产方法
|
AR103297A1
(es)
|
2014-12-30 |
2017-05-03 |
Forma Therapeutics Inc |
Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
|
MA41291A
(fr)
|
2014-12-30 |
2017-11-07 |
Forma Therapeutics Inc |
Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
|
JP2018504431A
(ja)
|
2015-02-05 |
2018-02-15 |
フォーマ セラピューティクス,インコーポレイテッド |
ユビキチン特異的プロテアーゼ7阻害物質としてのチエノピリミジノン
|
US9938300B2
(en)
|
2015-02-05 |
2018-04-10 |
Forma Therapeutics, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
US9840491B2
(en)
|
2015-02-05 |
2017-12-12 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
CN112843005B
(zh)
|
2015-05-22 |
2023-02-21 |
艾吉因生物股份有限公司 |
左乙拉西坦的延时释放药物组合物
|
MX2017015752A
(es)
|
2015-06-19 |
2018-04-13 |
Agenebio Inc |
Derivados de benzodiazepina, composiciones y metodos para tratar deterioro cognitivo.
|
US20180185298A1
(en)
|
2015-06-22 |
2018-07-05 |
Corium International, Inc. |
Transdermal Adhesive Composition Comprising A Poorly Soluble Therapeutic Agent
|
CN105367483B
(zh)
*
|
2015-11-20 |
2017-12-26 |
山东淄博新达制药有限公司 |
盐酸多奈哌齐的制备方法
|
US10851053B2
(en)
|
2016-06-08 |
2020-12-01 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
JP7174632B2
(ja)
|
2016-06-23 |
2022-11-17 |
コリウム, インコーポレイテッド |
親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
|
WO2018016714A1
(ko)
|
2016-07-20 |
2018-01-25 |
주식회사 엔솔바이오사이언스 |
신규 펩타이드 및 그 용도
|
CN116966166A
(zh)
|
2016-07-27 |
2023-10-31 |
考里安有限责任公司 |
碳酸氢钠原位转化驱动胺药物的透皮递送
|
AU2017301929B2
(en)
|
2016-07-27 |
2023-03-02 |
Corium Pharma Solutions, Inc. |
Memantine transdermal delivery systems
|
EP3490559A1
(en)
|
2016-07-27 |
2019-06-05 |
Corium International, Inc. |
Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
|
BR112019012821A2
(pt)
|
2016-12-19 |
2019-11-26 |
Agenebio Inc |
derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US10369187B2
(en)
|
2017-02-09 |
2019-08-06 |
Vanderbilt University |
Peptide regulators of JNK family kinases
|
CA3085342A1
(en)
|
2017-12-13 |
2019-06-20 |
Corium, Inc. |
Method for depot creation during transdermal drug delivery
|
AU2018392686A1
(en)
|
2017-12-20 |
2020-07-09 |
Corium Pharma Solutions, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
JP2021528427A
(ja)
|
2018-06-19 |
2021-10-21 |
エージンバイオ, インコーポレイテッド |
認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法
|
BR112021024054A2
(pt)
|
2019-05-31 |
2022-01-11 |
Tecnimede Soc Tecnico Medicinal Sa |
Composições farmacêuticas de combinação de dose fixa de liberação imediata, seus métodos e usos.
|
JP7452810B2
(ja)
*
|
2019-06-17 |
2024-03-19 |
東和薬品株式会社 |
固定化触媒を用いたフロー反応によるドネペジルの製造方法
|
KR20220059300A
(ko)
*
|
2020-11-02 |
2022-05-10 |
주식회사 종근당 |
인덴 유도체 프로드럭의 산부가염 및 이의 제조방법
|
KR102451185B1
(ko)
|
2021-08-05 |
2022-10-07 |
환인제약 주식회사 |
도네페질 함유 지속방출형 미립구
|
WO2024039886A1
(en)
|
2022-08-19 |
2024-02-22 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|